pcDNA3.1-MEF2C-HA Citations (7)
Originally described in: Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway.Kozhemyakina E, Cohen T, Yao TP, Lassar AB Mol Cell Biol. 2009 Nov;29(21):5751-62. Epub 2009 Aug 24. PubMed Journal
Articles Citing pcDNA3.1-MEF2C-HA
| Articles |
|---|
| Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus. Sakai Y, Ohkubo K, Matsushita Y, Akamine S, Ishizaki Y, Torisu H, Ihara K, Sanefuji M, Kim MS, Lee KU, Shaw CA, Lim J, Nakabeppu Y, Hara T. Eur J Med Genet. 2013 Sep;56(9):475-83. doi: 10.1016/j.ejmg.2013.06.009. Epub 2013 Jul 5. PubMed |
| Hypoxia/ischemia promotes CXCL10 expression in cardiac microvascular endothelial cells by NFkB activation. Xia JB, Liu GH, Chen ZY, Mao CZ, Zhou DC, Wu HY, Park KS, Zhao H, Kim SK, Cai DQ, Qi XF. Cytokine. 2016 May;81:63-70. doi: 10.1016/j.cyto.2016.02.007. Epub 2016 Feb 15. PubMed |
| Epilepsy-causing sequence variations in SIK1 disrupt synaptic activity response gene expression and affect neuronal morphology. Proschel C, Hansen JN, Ali A, Tuttle E, Lacagnina M, Buscaglia G, Halterman MW, Paciorkowski AR. Eur J Hum Genet. 2017 Feb;25(2):216-221. doi: 10.1038/ejhg.2016.145. Epub 2016 Dec 14. PubMed |
| Methyltransferase-like 21c methylates and stabilizes the heat shock protein Hspa8 in type I myofibers in mice. Wang C, Arrington J, Ratliff AC, Chen J, Horton HE, Nie Y, Yue F, Hrycyna CA, Tao WA, Kuang S. J Biol Chem. 2019 Sep 13;294(37):13718-13728. doi: 10.1074/jbc.RA119.008430. Epub 2019 Jul 25. PubMed |
| Recapitulation and Reversal of Schizophrenia-Related Phenotypes in Setd1a-Deficient Mice. Mukai J, Cannavo E, Crabtree GW, Sun Z, Diamantopoulou A, Thakur P, Chang CY, Cai Y, Lomvardas S, Takata A, Xu B, Gogos JA. Neuron. 2019 Nov 6;104(3):471-487.e12. doi: 10.1016/j.neuron.2019.09.014. Epub 2019 Oct 9. PubMed |
| MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease. Nath SR, Lieberman ML, Yu Z, Marchioretti C, Jones ST, Danby ECE, Van Pelt KM, Soraru G, Robins DM, Bates GP, Pennuto M, Lieberman AP. Acta Neuropathol. 2020 Jul;140(1):63-80. doi: 10.1007/s00401-020-02156-4. Epub 2020 Apr 18. PubMed |
| Muscle-specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling. Gorska AA, Sandmann C, Riechert E, Hofmann C, Malovrh E, Varma E, Kmietczyk V, Olschlager J, Jurgensen L, Kamuf-Schenk V, Stroh C, Furkel J, Konstandin MH, Sticht C, Boileau E, Dieterich C, Frey N, Katus HA, Doroudgar S, Volkers M. EMBO Rep. 2021 Dec 6;22(12):e52170. doi: 10.15252/embr.202052170. Epub 2021 Oct 4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.